Font Size: a A A
Keyword [Checkpoint inhibitors]
Result: 1 - 20 | Page: 1 of 6
1. Research On Cell Cycle G2/M Checkpoint Inhibitors Synthesis And Activity
2. Synergistic Effects Of The Immune Checkpoint Inhibitor CTLA-4 Combined With The Growth Inhibitor Lycorine In A Mouse Model Of Renal Cell Carcinoma
3. Genomic Alterations Of Hepatocellular Carcinoma By Panel-based Sequencing
4. Expression And Clinical Significance Of PD-1 /PD-L1 In Gastric Cancer
5. Evaluation Of PLGA/anti-CTLA-4 Suppressive Effect On Mouse Endometriosis Model
6. Research Progress On The Application Of Immunotherapy In Multiple Myeloma
7. Preparation Of Injectable Hydrogel Tumor Vaccine And Study Of Its Effect On Tumor Immunotherapy
8. Screening And Mechanism Research Of PD-L1/PD-1 Checkpoint Inhibitors And Study On The Anticancer Mechanisms Of Axl Inhibitor,R428
9. Prognostic And Predictive Roles Of TMB And CNA Across Metastatic Pan-cancer:immunotherapeutic Implications
10. Part 1:clinical Observation Of Immune Checkpoint Inhibitors In The Treatment Of Advanced Pancreatic Cancer And Biliary Tract Cancer Part 2:the Expression Of Notch Signaling Pathway Related Proteins In SCLC
11. Synergistic Effect Of Radiofrequency Ablation And Immune Checkpoint Inhibitors On Advanced Kidney Cancer And Its Imaging Evaluation
12. Efficacy Evaluation And Candidate Biomarkers Screening For Anti-PD-1 Therapy In Advanced Lung Cancer
13. Toxicities And Management Of Immune Checkpoint Inhibitors In Cancer Immunotherapy
14. Post-marketing Study Of Safety Of Immune Checkpoint Inhibitor Based On Spontaneous Reporting System
15. New Progress Of Immune Checkpoint Inhibitors In The Treatment Of Lung Cancer
16. The Efficacy And Safety Of PD-1/PD-L1 Inhibitors Versus Chemotherapy In The Treatment Of Non Small Cell Lung Cancer-a Meta Analysis
17. The Incidence And Risk Factors Of Pneumonitis In Patients Treated With Immune Checkpoint Inhibitors
18. Efficacy And Immune-related Adverse Events Induced By PD-1/PD-L1 And CTLA-4 Inhibitors In Advanced NSCLC
19. Efficacy Of PD-1/PD-L1 Immune Checkpoint Inhibitors For Advanced Nsclc According To PD-L1 Expression: A Meta-analysis
20. Clinical Pathological Characteristics Of Liver Injury Associated With Immune Checkpoint Inhibitors
  <<First  <Prev  Next>  Last>>  Jump to